Physician profile
Jonathan Riggin Lowe
NPI 1932658697
$6,039.68
in general payments reported to CMS, 2019-2025
20 companies · $1,532 in 2025
The $1,532 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $630 · 2022: $1,292 · 2023: $759 · 2024: $1,826 · 2025: $1,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,557 · Travel and Lodging: $843 · Consulting Fee: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,557.14 |
| Travel and Lodging | $843.30 |
| Consulting Fee | $717.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,282.78 | 2021-2025 | |
| Inspire Medical Systems, INC. | $1,854.86 | 2023-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $635.89 | 2021-2025 | Airsupra, Tezspire |
| Janssen Pharmaceuticals, INC | $275.58 | 2021-2024 | Spravato, Xarelto |
| Regeneron Healthcare Solutions, INC. | $207.19 | 2021-2023 | Dupixent |
| Glaxosmithkline, LLC. | $187.51 | 2021-2022 | |
| Mylan Specialty L.P. | $117.18 | 2021-2023 | Yupelri |
| Axsome Therapeutics, INC. | $85.55 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.75 | 2023-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $57.48 | 2022 | |
| Pulmonx Corporation | $44.86 | 2022-2024 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Inogen, INC. | $38.33 | 2025 | |
| Abiomed | $33.59 | 2025 | |
| Advanced Respiratory, INC | $24.83 | 2021 | |
| Amgen INC. | $24.26 | 2024 | Tezspire |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.70 | 2025 | Zepbound |
| Baxter Healthcare | $19.64 | 2023 | Hillrom - Life 2000 Ventilation System |
| Pfizer INC. | $18.51 | 2022 | |
| Merck Sharp & Dohme LLC | $17.93 | 2021 | |
| 3b Medical, INC. | $13.26 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.